MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference
VALENCIA, Calif.--(BUSINESS WIRE)--May. 8, 2013--
MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing
and commercializing treatments for diabetes, announced today that it
will present at the Bank of America Merrill Lynch 2013 Health Care
Conference on Wednesday, May 15, 2013 at 1:40 pm Pacific Time at the
Encore at the Wynn Hotel in Las Vegas, Nevada.
Interested parties can access a link to the live webcast of the
presentations from the News & Events section of the Company's website at http://www.mannkindcorp.com.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery,
development and commercialization of therapeutic products for patients
with diseases such as diabetes. Its lead product candidate, AFREZZA®, is
in late stage clinical investigation for the treatment of adults with
type 1 or type 2 diabetes for the control of hyperglycemia.
MannKind maintains a website at http://www.mannkindcorp.com
to which MannKind regularly posts copies of its press releases as well
as additional information about MannKind. Interested persons can
subscribe on the MannKind website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its reports
with the Securities and Exchange Commission or posts certain other
information to the website.
Source: MannKind Corporation
MannKind Corporation
Matthew J. Pfeffer
Corporate Vice
President and Chief Financial Officer
661-775-5300
mpfeffer@mannkindcorp.com